Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tolås

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Gastroenterology|January 23, 1998
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapyF Lerang, B Moum, J B Haug, et al.
The American Journal of Gastroenterology|February 19, 1998
Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistanceF Lerang, B Moum, E Ragnhildstveit, et al.
The American Journal of Gastroenterology|February 1, 1997
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?F Lerang, B Moum, J B Haug, et al.
The American Journal of Gastroenterology|April 1, 1997
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up studyF Lerang, B Moum, E Ragnhildstveit, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Gastroenterology|January 23, 1998
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapyF Lerang, B Moum, J B Haug, et al.
The American Journal of Gastroenterology|February 19, 1998
Simplified 10-day bismuth triple therapy for cure of Helicobacter pylori infection: experience from clinical practice in a population with a high frequency of metronidazole resistanceF Lerang, B Moum, E Ragnhildstveit, et al.
The American Journal of Gastroenterology|February 1, 1997
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?F Lerang, B Moum, J B Haug, et al.
The American Journal of Gastroenterology|April 1, 1997
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up studyF Lerang, B Moum, E Ragnhildstveit, et al.
Pageof 1